Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 701

1.

Unusual structures of CCTG repeats and their participation in repeat expansion.

Guo P, Lam SL.

Biomol Concepts. 2016 Dec 1;7(5-6):331-340. doi: 10.1515/bmc-2016-0024. Review.

PMID:
27879482
2.

Eckardt Keratoprosthesis for Tectonic Repair of a Large Corneal Perforation.

Helsen S, Ní Dhubhghaill S, Zakaria N, Koppen C.

Cornea. 2016 Aug;35(8):1147-9. doi: 10.1097/ICO.0000000000000887. Review.

PMID:
27191673
3.

Sleep in Neuromuscular Diseases.

Fermin AM, Afzal U, Culebras A.

Sleep Med Clin. 2016 Mar;11(1):53-64. doi: 10.1016/j.jsmc.2015.10.005. Epub 2016 Jan 9. Review.

PMID:
26972033
4.

[Impairment of Odor Recognition in Myotonic Dystrophy Type 1].

Masaoka Y.

Brain Nerve. 2016 Feb;68(2):145-50. doi: 10.11477/mf.1416200364. Review. Japanese.

PMID:
26873234
5.

[Social Cognitive Impairment in Myotonic Dystrophy Type 1].

Kobayakawa M.

Brain Nerve. 2016 Feb;68(2):137-44. doi: 10.11477/mf.1416200363. Review. Japanese.

PMID:
26873233
6.

[Clinical Importance of Central Nervous System Dysfunction in Myopathy].

Matsumura T.

Brain Nerve. 2016 Feb;68(2):109-18. doi: 10.11477/mf.1416200360. Review. Japanese.

PMID:
26873230
7.

Interventions for dysphagia in long-term, progressive muscle disease.

Jones K, Pitceathly RD, Rose MR, McGowan S, Hill M, Badrising UA, Hughes T.

Cochrane Database Syst Rev. 2016 Feb 9;2:CD004303. doi: 10.1002/14651858.CD004303.pub4. Review.

PMID:
26859621
8.

A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies.

Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N.

Can J Neurol Sci. 2016 Jan;43(1):163-77. doi: 10.1017/cjn.2015.311. Review.

PMID:
26786644
9.

Disease-associated repeat instability and mismatch repair.

Schmidt MH, Pearson CE.

DNA Repair (Amst). 2016 Feb;38:117-26. doi: 10.1016/j.dnarep.2015.11.008. Epub 2015 Dec 12. Review.

PMID:
26774442
10.

Congenital myotonic dystrophy: ventriculomegaly and shunt considerations for the pediatric neurosurgeon.

Mutchnick IS, Thatikunta MA, Gump WC, Stewart DL, Moriarty TM.

Childs Nerv Syst. 2016 Apr;32(4):609-16. doi: 10.1007/s00381-015-2993-y. Epub 2016 Jan 8. Review.

PMID:
26747623
11.

Studies on Chloride Channels and their Modulators.

Patil VM, Gupta SP.

Curr Top Med Chem. 2016;16(16):1862-76. Review.

PMID:
26667116
12.

Sudden cardiac death in neuromuscular disorders.

Finsterer J, Stöllberger C, Maeztu C.

Int J Cardiol. 2016 Jan 15;203:508-15. doi: 10.1016/j.ijcard.2015.10.176. Epub 2015 Oct 28. Review.

PMID:
26551884
13.

[Literature review of the importance of retinal examination in two genetic neuromuscular diseases (DM1 and FSHD). Potential clinical applications].

Brignol TN.

J Fr Ophtalmol. 2015 Dec;38(10):e259-60. doi: 10.1016/j.jfo.2015.03.024. Epub 2015 Nov 5. Review. French. No abstract available.

PMID:
26547227
14.

Modulation of nuclear PI-PLCbeta1 during cell differentiation.

Cocco L, Manzoli L, Faenza I, Ramazzotti G, Yang YR, McCubrey JA, Suh PG, Follo MY.

Adv Biol Regul. 2016 Jan;60:1-5. doi: 10.1016/j.jbior.2015.10.008. Epub 2015 Oct 26. Review.

PMID:
26525203
15.

Workshop Report: consensus on biomarkers of cerebral involvement in myotonic dystrophy, 2-3 December 2014, Milan, Italy.

Bosco G, Diamanti S, Meola G; DM-CNS Group..

Neuromuscul Disord. 2015 Oct;25(10):813-23. doi: 10.1016/j.nmd.2015.07.016. Epub 2015 Aug 4. No abstract available.

PMID:
26341263
16.

An update on RNA-targeting therapies for neuromuscular disorders.

Jirka S, Aartsma-Rus A.

Curr Opin Neurol. 2015 Oct;28(5):515-21. doi: 10.1097/WCO.0000000000000235. Review.

PMID:
26280937
17.

Role of adipose tissue in the pathogenesis of cardiac arrhythmias.

Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P.

Heart Rhythm. 2016 Jan;13(1):311-20. doi: 10.1016/j.hrthm.2015.08.016. Epub 2015 Aug 12. Review.

PMID:
26277495
18.

Trinucleotide repeat expansions in human breast cancer-susceptibility genes: relevant targets for aspirin chemoprevention?

Altinoz MA, Tunalı NE.

Clin Transl Oncol. 2016 Jan;18(1):9-17. doi: 10.1007/s12094-015-1356-1. Epub 2015 Jul 22. Review.

PMID:
26199016
19.

RNA Structures as Mediators of Neurological Diseases and as Drug Targets.

Bernat V, Disney MD.

Neuron. 2015 Jul 1;87(1):28-46. doi: 10.1016/j.neuron.2015.06.012. Review.

20.

Therapeutic Approaches for Dominant Muscle Diseases: Highlight on Myotonic Dystrophy.

Klein AF, Dastidar S, Furling D, Chuah MK.

Curr Gene Ther. 2015;15(4):329-37. Review.

PMID:
26122101

Supplemental Content

Loading ...
Support Center